Zymeworks Inc.ZYMENASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -12.21% |
| Q3 2025 | 3.28% |
| Q2 2025 | -3.61% |
| Q1 2025 | -3.57% |
| Q4 2024 | 1.95% |
| Q3 2024 | 24.65% |
| Q2 2024 | -8.99% |
| Q1 2024 | 25.54% |
| Q4 2023 | -22.12% |
| Q3 2023 | -16.83% |
| Q2 2023 | -14.17% |
| Q1 2023 | -13.32% |
| Q4 2022 | 42.78% |
| Q3 2022 | -33.78% |
| Q2 2022 | -10.38% |
| Q1 2022 | 13.77% |
| Q4 2021 | 10.12% |
| Q3 2021 | -1.61% |
| Q2 2021 | 14.52% |
| Q1 2021 | 10.11% |
| Q4 2020 | -26.07% |
| Q3 2020 | 36.74% |
| Q2 2020 | 7.69% |
| Q1 2020 | -18.80% |
| Q4 2019 | -99.42% |
| Q3 2019 | 32946.04% |
| Q2 2019 | 36.11% |
| Q1 2019 | 24.03% |
| Q4 2018 | -0.37% |
| Q3 2018 | -7.98% |
| Q2 2018 | 17.45% |
| Q1 2018 | 1.62% |
| Q4 2017 | 11.73% |
| Q3 2017 | 39.04% |
| Q2 2017 | -8.49% |
| Q1 2017 | 1.57% |
| Q4 2016 | -8.62% |
| Q3 2016 | -4.54% |
| Q2 2016 | 29.14% |
| Q1 2016 | -3.90% |